Sequential Enzalutamide–Docetaxel Versus Abiraterone–Docetaxel Therapy in Castration‐Resistant Prostate Cancer: A Subanalysis of the <scp>ENABLE</scp> Study

Manabu Kamiyama, Kouji Izumi, Takahiko Mitsui, Takashi Shima, Yuki Kato, Koji Mita, Takehiko Okamura, Shogo Inoue, Seiji Hoshi, Nobumichi Tanaka, Yuko Yoshio, Shuichi Tatarano, Ippei Chikazawa, Noriyasu Kawai, Kohei Hashimoto, Takashi Fukagai, Kazuyoshi Shigehara, Shizuko Takahara, Atsushi Mizokami

Open source

DOI: 10.1111/iju.70599
Published: 2026-08
Container: International Journal of Urology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/iju.70599,
  title = {Sequential Enzalutamide–Docetaxel Versus Abiraterone–Docetaxel Therapy in Castration‐Resistant Prostate Cancer: A Subanalysis of the
                    <scp>ENABLE</scp>
                    Study},
  author = {Manabu Kamiyama and Kouji Izumi and Takahiko Mitsui and Takashi Shima and Yuki Kato and Koji Mita and Takehiko Okamura and Shogo Inoue and Seiji Hoshi and Nobumichi Tanaka and Yuko Yoshio and Shuichi Tatarano and Ippei Chikazawa and Noriyasu Kawai and Kohei Hashimoto and Takashi Fukagai and Kazuyoshi Shigehara and Shizuko Takahara and Atsushi Mizokami},
  year = {2026},
  journal = {International Journal of Urology},
  doi = {10.1111/iju.70599},
  url = {https://doi.org/10.1111/iju.70599}
}

RIS

TY  - JOUR
TI  - Sequential Enzalutamide–Docetaxel Versus Abiraterone–Docetaxel Therapy in Castration‐Resistant Prostate Cancer: A Subanalysis of the
                    <scp>ENABLE</scp>
                    Study
AU  - Manabu Kamiyama
AU  - Kouji Izumi
AU  - Takahiko Mitsui
AU  - Takashi Shima
AU  - Yuki Kato
AU  - Koji Mita
AU  - Takehiko Okamura
AU  - Shogo Inoue
AU  - Seiji Hoshi
AU  - Nobumichi Tanaka
AU  - Yuko Yoshio
AU  - Shuichi Tatarano
AU  - Ippei Chikazawa
AU  - Noriyasu Kawai
AU  - Kohei Hashimoto
AU  - Takashi Fukagai
AU  - Kazuyoshi Shigehara
AU  - Shizuko Takahara
AU  - Atsushi Mizokami
PY  - 2026
JO  - International Journal of Urology
DO  - 10.1111/iju.70599
UR  - https://doi.org/10.1111/iju.70599
ER  -

APA

Kamiyama, M., Izumi, K., Mitsui, T., Shima, T., Kato, Y., Mita, K., Okamura, T., Inoue, S., Hoshi, S., Tanaka, N., Yoshio, Y., Tatarano, S., Chikazawa, I., Kawai, N., Hashimoto, K., Fukagai, T., Shigehara, K., Takahara, S., & Mizokami, A. (2026). Sequential Enzalutamide–Docetaxel Versus Abiraterone–Docetaxel Therapy in Castration‐Resistant Prostate Cancer: A Subanalysis of the <scp>ENABLE</scp> Study. International Journal of Urology. https://doi.org/10.1111/iju.70599

Source records

crossref · retrieved 2026-09-26T00:24:54.759Z